Biotech expert: "Microdosing" could prevent trial problems

03/19/2006 | Guardian (London), The

Cambridge Antibody Technology's former chief medical officer says the London clinical trial that put six participants in the hospital suggests new procedures need to be introduced. Dr. David Glover said microdosing, which involves testing drugs on a patient's arm rather than treating the whole person, could avert some trial problems.

View Full Article in:

Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Actuary
NTA Life
Addison, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA